These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. Briganti A, Salonia A, Gallina A, Saccà A, Montorsi P, Rigatti P, Montorsi F. Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835 [Abstract] [Full Text] [Related]
11. Non-arteritic anterior ischemic optic neuropathy, PDE-5 inhibitors, and amiodarone: may there be a sex hormone effect for the eye? Verit A. Med Hypotheses; 2007 May; 69(2):470-1. PubMed ID: 17280789 [No Abstract] [Full Text] [Related]
14. Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link? Hatzimouratidis K. Curr Urol Rep; 2007 Nov; 8(6):482-90. PubMed ID: 18042329 [Abstract] [Full Text] [Related]
15. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Schwarz ER, Kapur V, Rodriguez J, Rastogi S, Rosanio S. Int J Impot Res; 2007 Nov; 19(2):139-48. PubMed ID: 16761012 [Abstract] [Full Text] [Related]
16. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey. Kim NN. Int J Impot Res; 2003 Oct; 15 Suppl 5():S13-9. PubMed ID: 14551572 [Abstract] [Full Text] [Related]